[
  {
    "ts": null,
    "headline": "Merck (MRK) Outperforms Broader Market: What You Need to Know",
    "summary": "In the closing of the recent trading day, Merck (MRK) stood at $78.56, denoting a +1.24% move from the preceding trading day.",
    "url": "https://finnhub.io/api/news?id=9d15e5051a292891968bdbeb2128932f36319f657b7f948efaf01482258a4a6b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758923104,
      "headline": "Merck (MRK) Outperforms Broader Market: What You Need to Know",
      "id": 136897041,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "In the closing of the recent trading day, Merck (MRK) stood at $78.56, denoting a +1.24% move from the preceding trading day.",
      "url": "https://finnhub.io/api/news?id=9d15e5051a292891968bdbeb2128932f36319f657b7f948efaf01482258a4a6b"
    }
  },
  {
    "ts": null,
    "headline": "Stocks Close Higher After Trump Unveils New Tariffs",
    "summary": "U.S. stocks ended higher Friday after a three-day losing streak, showing investors aren’t concerned about the broad impact of new tariffs on drugs, trucks and furniture.",
    "url": "https://finnhub.io/api/news?id=2e7103a4b46ce12e8363a0817076daf0d2e8a329f7bbfc6c7af0a58bdf05dbea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758918660,
      "headline": "Stocks Close Higher After Trump Unveils New Tariffs",
      "id": 136896929,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "U.S. stocks ended higher Friday after a three-day losing streak, showing investors aren’t concerned about the broad impact of new tariffs on drugs, trucks and furniture.",
      "url": "https://finnhub.io/api/news?id=2e7103a4b46ce12e8363a0817076daf0d2e8a329f7bbfc6c7af0a58bdf05dbea"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.",
    "summary": "Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.",
    "url": "https://finnhub.io/api/news?id=419b097963dfa4a43b4a84cafebb9ef46b0d55a5dafa5472eb05116de58124f3",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758905460,
      "headline": "Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.",
      "id": 136921039,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Eli Lilly, Pfizer, Amgen Stocks Rise After Trump’s 100% Pharma Tariff Threat. Here’s Why.",
      "url": "https://finnhub.io/api/news?id=419b097963dfa4a43b4a84cafebb9ef46b0d55a5dafa5472eb05116de58124f3"
    }
  },
  {
    "ts": null,
    "headline": "Trump's 100% Drug Tariff Just Landed--Here's Why Wall Street Isn't Panicking",
    "summary": "Big Pharma's US factory spree might just outmaneuver Trump's boldest trade threat yet",
    "url": "https://finnhub.io/api/news?id=04bb35735322ae121f0620c6de951b3eb84a334bdaecd3efe42afa192054d6ba",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758901699,
      "headline": "Trump's 100% Drug Tariff Just Landed--Here's Why Wall Street Isn't Panicking",
      "id": 136897043,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Big Pharma's US factory spree might just outmaneuver Trump's boldest trade threat yet",
      "url": "https://finnhub.io/api/news?id=04bb35735322ae121f0620c6de951b3eb84a334bdaecd3efe42afa192054d6ba"
    }
  },
  {
    "ts": null,
    "headline": "Merck’s (MRK) Oncology Portfolio Gets Shot in the Arm with QLEX Nod",
    "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks in Goldman Sachs’ portfolio. On September 19, the company announced FDA approval for KEYTRUDA QLEX injection, the first subcutaneous version of its blockbuster cancer drug KEYTRUDA. Unlike the traditional intravenous (IV) form, QLEX can be administered subcutaneously (under the skin) in as little as one […]",
    "url": "https://finnhub.io/api/news?id=25971b012b9744ea72374768461a575be458c74c0dca655de49437dfd483b017",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758899392,
      "headline": "Merck’s (MRK) Oncology Portfolio Gets Shot in the Arm with QLEX Nod",
      "id": 136892739,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck & Co. Inc. (NYSE:MRK) is one of the best value stocks in Goldman Sachs’ portfolio. On September 19, the company announced FDA approval for KEYTRUDA QLEX injection, the first subcutaneous version of its blockbuster cancer drug KEYTRUDA. Unlike the traditional intravenous (IV) form, QLEX can be administered subcutaneously (under the skin) in as little as one […]",
      "url": "https://finnhub.io/api/news?id=25971b012b9744ea72374768461a575be458c74c0dca655de49437dfd483b017"
    }
  },
  {
    "ts": null,
    "headline": "US, European pharma stocks steady after Trump's tariff move, Asia slips",
    "summary": "SINGAPORE/SHANGHAI (Reuters) -Shares of U.S. and European pharmaceutical firms were little changed on Friday, while Asian drugmakers declined, after President Donald Trump announced 100% tariffs on branded drugs imported by firms that are not building plants in the U.S.  Analysts said the move was widely expected and unlikely to materially hit the industry, given that most drugmakers have pledged billions of dollars in U.S. manufacturing investments.  The conditions sort of weaken the announcement, which is probably why the market is not overly reacting, said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.",
    "url": "https://finnhub.io/api/news?id=81cc1afbda3c970156aecb3f0a49a5c39bb2c5b4269afd5e64476eefa96f0230",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758897964,
      "headline": "US, European pharma stocks steady after Trump's tariff move, Asia slips",
      "id": 136915782,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "SINGAPORE/SHANGHAI (Reuters) -Shares of U.S. and European pharmaceutical firms were little changed on Friday, while Asian drugmakers declined, after President Donald Trump announced 100% tariffs on branded drugs imported by firms that are not building plants in the U.S.  Analysts said the move was widely expected and unlikely to materially hit the industry, given that most drugmakers have pledged billions of dollars in U.S. manufacturing investments.  The conditions sort of weaken the announcement, which is probably why the market is not overly reacting, said Peter Cardillo, chief market economist at Spartan Capital Securities in New York.",
      "url": "https://finnhub.io/api/news?id=81cc1afbda3c970156aecb3f0a49a5c39bb2c5b4269afd5e64476eefa96f0230"
    }
  },
  {
    "ts": null,
    "headline": "Trump's new tariffs on pharma, furniture, & trucks: What to know",
    "summary": "President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White House columnist for The Hill, Niall Stanage, and Yahoo Finance senior reporter Brooke DiPalma outline the details of the tariff policy and examine the respective market reactions. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
    "url": "https://finnhub.io/api/news?id=d7991ae95fc41cdc2d33538ff9b6e84b21dd938423a6bbf5b5aea179b58efa25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758895101,
      "headline": "Trump's new tariffs on pharma, furniture, & trucks: What to know",
      "id": 136892599,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "President Trump announced sweeping new tariffs on pharmaceuticals, heavy trucks, and furniture imports. The duty on pharmaceuticals sits at 100% for patented drugs unless the producer is building a manufacturing plant in the US. White House columnist for The Hill, Niall Stanage, and Yahoo Finance senior reporter Brooke DiPalma outline the details of the tariff policy and examine the respective market reactions. To watch more expert insights and analysis on the latest market action, check out more Morning Brief.",
      "url": "https://finnhub.io/api/news?id=d7991ae95fc41cdc2d33538ff9b6e84b21dd938423a6bbf5b5aea179b58efa25"
    }
  },
  {
    "ts": null,
    "headline": "Eli Lilly, Merck, Pfizer Stocks Rise After Trump Unveils Pharma Tariffs",
    "summary": "Big U.S. and European drugmakers largely brushed off President Trump's new pharmaceutical tariffs, though some Asian companies suffered losses.  Trump on Thursday announced a 100% tariff on branded or patented drugs from companies that aren't building plants in America.  Generic drugs are exempt from the levy.",
    "url": "https://finnhub.io/api/news?id=4d27bfd0b6a8bdded47d43f3896fadc309e37c9e690cc4233457e9f6456324dc",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758894528,
      "headline": "Eli Lilly, Merck, Pfizer Stocks Rise After Trump Unveils Pharma Tariffs",
      "id": 136892602,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Big U.S. and European drugmakers largely brushed off President Trump's new pharmaceutical tariffs, though some Asian companies suffered losses.  Trump on Thursday announced a 100% tariff on branded or patented drugs from companies that aren't building plants in America.  Generic drugs are exempt from the levy.",
      "url": "https://finnhub.io/api/news?id=4d27bfd0b6a8bdded47d43f3896fadc309e37c9e690cc4233457e9f6456324dc"
    }
  },
  {
    "ts": null,
    "headline": "MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?",
    "summary": "Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRK's momentum and BMY navigating generic headwinds.",
    "url": "https://finnhub.io/api/news?id=cd7b1eae56c22a726ff1d8ceb6db5b596c1e1074f6c26bc32d3be4fef641810e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758894000,
      "headline": "MRK vs. BMY: Which Pharma Stock Is the Smarter Pick Now?",
      "id": 136892743,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck and Bristol Myers face diverging growth paths, with Keytruda driving MRK's momentum and BMY navigating generic headwinds.",
      "url": "https://finnhub.io/api/news?id=cd7b1eae56c22a726ff1d8ceb6db5b596c1e1074f6c26bc32d3be4fef641810e"
    }
  },
  {
    "ts": null,
    "headline": "Big pharma stocks rise as Street reacts to latest presidential tariff plan",
    "summary": "Shares of some big drugmakers jumped ahead of broader indexes Friday as Wall Street started sorting out President Donald Trump’s latest tariff announcement.  The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply to companies building U.S. manufacturing plants.  Several big drugmakers like Merck & Co. Inc., Eli Lilly and Co. and Johnson & Johnson have announced U.S. expansion plans.",
    "url": "https://finnhub.io/api/news?id=4b37a7be94a8687633bc24664a4565f06a7e6f2105839c6b4d6ce3ced85e7422",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758892447,
      "headline": "Big pharma stocks rise as Street reacts to latest presidential tariff plan",
      "id": 136892606,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Shares of some big drugmakers jumped ahead of broader indexes Friday as Wall Street started sorting out President Donald Trump’s latest tariff announcement.  The president said late Thursday that he would place 100% import taxes on pharmaceuticals starting Oct. 1, but those tariffs would not apply to companies building U.S. manufacturing plants.  Several big drugmakers like Merck & Co. Inc., Eli Lilly and Co. and Johnson & Johnson have announced U.S. expansion plans.",
      "url": "https://finnhub.io/api/news?id=4b37a7be94a8687633bc24664a4565f06a7e6f2105839c6b4d6ce3ced85e7422"
    }
  },
  {
    "ts": null,
    "headline": "Analyst Highlights Growth Catalysts for Merck (MRK) Stock",
    "summary": "We recently published Wall Street Analysts Like These 10 Stocks. Merck & Co., Inc. (NYSE:MRK) is one of the stocks analysts were recently talking about. Bill Nygren, Oakmark Funds partner and CIO, recently said during a program on CNBC that he likes Merck & Co., Inc. (NYSE:MRK). Here is how the analyst made the bull […]",
    "url": "https://finnhub.io/api/news?id=d10162dd5fe74ff047ab52f37c9ebf438b25907888914d68bafad8c2cbb1aa4f",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758888699,
      "headline": "Analyst Highlights Growth Catalysts for Merck (MRK) Stock",
      "id": 136892745,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "We recently published Wall Street Analysts Like These 10 Stocks. Merck & Co., Inc. (NYSE:MRK) is one of the stocks analysts were recently talking about. Bill Nygren, Oakmark Funds partner and CIO, recently said during a program on CNBC that he likes Merck & Co., Inc. (NYSE:MRK). Here is how the analyst made the bull […]",
      "url": "https://finnhub.io/api/news?id=d10162dd5fe74ff047ab52f37c9ebf438b25907888914d68bafad8c2cbb1aa4f"
    }
  },
  {
    "ts": null,
    "headline": "Merck: Game-Changing Oncology Drugs Power Stock Surge",
    "summary": "Merck: Game-Changing Oncology Drugs Power Stock Surge",
    "url": "https://finnhub.io/api/news?id=f3dff6892d38ff7d5fe4aae97d30acabd98a129f2483a7520b4aceab167f87a5",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758887176,
      "headline": "Merck: Game-Changing Oncology Drugs Power Stock Surge",
      "id": 136893400,
      "image": "",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "",
      "url": "https://finnhub.io/api/news?id=f3dff6892d38ff7d5fe4aae97d30acabd98a129f2483a7520b4aceab167f87a5"
    }
  },
  {
    "ts": null,
    "headline": "President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio",
    "summary": "Explore how Trump's MFN pricing and 100% drug import tariffs impact pharma stocks.",
    "url": "https://finnhub.io/api/news?id=f87454e5d95e6da200bbd80a0968fd7d3fa1631bf2ee86d435f94ffa5e918741",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758885865,
      "headline": "President Trump's 100% Tariff Threat: What It Means For Your Pharma Portfolio",
      "id": 136892883,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1645808639/image_1645808639.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Explore how Trump's MFN pricing and 100% drug import tariffs impact pharma stocks.",
      "url": "https://finnhub.io/api/news?id=f87454e5d95e6da200bbd80a0968fd7d3fa1631bf2ee86d435f94ffa5e918741"
    }
  },
  {
    "ts": null,
    "headline": "Dow up 314 points on gains for shares of Boeing, IBM",
    "summary": "Dow up 314 points on gains for shares of Boeing, IBM",
    "url": "https://finnhub.io/api/news?id=9a9ae2924f974d755b4cd84b4ce1ddef42141e7adcf415bb0ee84aba95788fbe",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758879900,
      "headline": "Dow up 314 points on gains for shares of Boeing, IBM",
      "id": 136920998,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow up 314 points on gains for shares of Boeing, IBM",
      "url": "https://finnhub.io/api/news?id=9a9ae2924f974d755b4cd84b4ce1ddef42141e7adcf415bb0ee84aba95788fbe"
    }
  },
  {
    "ts": null,
    "headline": "Trump Plans New Tariff Push With 100% Rate on Patented Drugs",
    "summary": "“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump posted on social media Thursday, without offering specifics on which producers will be impacted.  “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”",
    "url": "https://finnhub.io/api/news?id=405bb7558df757d18271ae19363d916f178b5c7324db98af9d47ec112ffd5d4e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1758871035,
      "headline": "Trump Plans New Tariff Push With 100% Rate on Patented Drugs",
      "id": 136890601,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "“Starting October 1st, 2025, we will be imposing a 100% Tariff on any branded or patented Pharmaceutical Product, unless a Company IS BUILDING their Pharmaceutical Manufacturing Plant in America,” Trump posted on social media Thursday, without offering specifics on which producers will be impacted.  “There will, therefore, be no Tariff on these Pharmaceutical Products if construction has started.”",
      "url": "https://finnhub.io/api/news?id=405bb7558df757d18271ae19363d916f178b5c7324db98af9d47ec112ffd5d4e"
    }
  }
]